InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
T+90 hit rate
18%
T+90 mean return
-24.2%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Estepan Ian Michael, Chief Financial Officer. Officer active across 1 company, notably Sarepta Therapeutics, Inc.. Aggregated, 18 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €742k. History available since 8 September 2021. The latest transaction was filed on 4 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
5,500 sharesCommon StockSEC:0000950170-25-037519:0
17,500 sharesCommon StockSEC:0000950170-25-036695:0
1,370 shares@ US$101.346.5% of flowCommon StockSEC:0000950170-25-035003:0
557 shares@ US$103.772.7% of flowCommon StockSEC:0000950170-25-032760:0
14,267 shares@ US$12.008.0% of flowCommon StockSEC:0000950170-25-011959:0
250 shares0Common StockSEC:0000950170-24-141250:0
5,985 shares@ US$137.3636.1% of flowCommon StockSEC:0000950170-24-103070:0
6,250 sharesCommon StockSEC:0000950170-24-077519:0
526 shares@ US$120.492.8% of flowCommon StockSEC:0000950170-24-029529:0
1,389 shares@ US$125.327.8% of flowCommon StockSEC:0000950170-24-027498:0
365 shares@ US$126.192.1% of flowCommon StockSEC:0000950170-24-026605:0
744 shares@ US$153.195.3% of flowCommon StockSEC:0001209191-23-018020:0
1,370 shares@ US$157.219.9% of flowCommon StockSEC:0001209191-23-017408:0
378 shares@ US$147.572.6% of flowCommon StockSEC:0001209191-23-016055:0
1,308 shares@ US$79.200.0041% mcap28.0% of flowCommon StockSEC:0001209191-22-017347:0
376 shares@ US$75.050.0011% mcap7.5% of flowCommon StockSEC:0001209191-22-014408:0
1,623 shares@ US$78.290.0048% mcap32.2% of flowCommon StockSEC:0001209191-21-055383:0
1,623 shares@ US$78.295.2% of flowCommon StockSEC:0001209191-21-055383
18 of 18 declarations
About Estepan Ian Michael
Estepan Ian Michael is the Chief Financial Officer of Sarepta Therapeutics, Inc. He is responsible for the financial management of the company, including budget planning and risk management. His expertise in finance is crucial to support the company's growth and profitability.
